Final answer:
Antiplatelet therapy, often referred to as dual antiplatelet therapy (DAPT), is recommended for patients with symptomatic peripheral arterial disease (PAD) to prevent blood clotting, improve blood flow, and reduce cardiovascular symptoms.
Step-by-step explanation:
Antiplatelet therapy is indicated for all patients with symptomatic peripheral arterial disease (PAD). PAD is a condition where the narrowing of peripheral arteries, typically in the legs, is due to atherosclerosis, and it generally causes intermittent pain in the legs when walking, known as intermittent claudication. Other symptoms of PAD can include skin ulcers, bluish skin, cold skin, or poor nail and hair growth in the affected leg(s).
When PAD is diagnosed, it is crucial to treat underlying atherosclerosis to prevent further complications like heart attacks or strokes. Medications that help to prevent clotting, such as aspirin or other antiplatelet drugs, are usually prescribed. This is often referred to as dual antiplatelet therapy (DAPT) when combined. These medications work by reducing the tendency for blood clots to form, thus improving blood flow and reducing symptoms of conditions such as high blood pressure and heart failure, which are also related to cardiovascular disease.
For patients with PAD, these therapies can alleviate the symptoms during exercise or stress, when the partially occluded artery struggles to pump sufficient quantities of blood or the smooth muscle in the walls of the vessel undergoes spasm.